Matthew Pauls

Affiliations

  • Director at Pelthos Therapeutics Inc. (PTHS), 2025-07-08
  • at Soleno Therapeutics Inc (SLNO), 2025-06-09
  • Chief Executive Officer at Savara Inc (SVRA), 2024-12-16
  • Director at Zyla Life Sciences (ZCOR), 2020-05-21
  • President & Ceo at Strongbridge Biopharma Plc (SBBP), 2019-02-22
  • Chief Commercial Officer at Insmed Inc (INSM), 2014-06-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SVRA $1.06 6,500 $6,889.35 383,672 2021-12-08 Filing
SVRA $1.10 10,000 $10,954.00 377,172 2021-12-02 Filing
SVRA $1.07 2,150 $2,289.75 367,172 2021-11-19 Filing
SVRA $1.11 10,000 $11,100.00 365,022 2021-11-19 Filing
SVRA $1.10 10,000 $11,000.00 355,022 2021-11-18 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SLNO $71.55 5,937 $424,797.10 6,500 2025-03-28 Filing
SVRA $3.31 54,702 $180,828.40 1,536,379 2024-12-16 Filing
SVRA $4.71 84,000 $395,900.40 1,302,674 2023-12-28 Filing